Enzyme replacement therapy and Fabry kidney disease: quo vadis?
Warnock
David G
DG
D018450:Disease Progression; D000795:Fabry Disease / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D000519:alpha-Galactosidase / Q000627:therapeutic use*
D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta